PROCEPT BioRobotics CorporationPRCTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +66.29% | +56.57% | +55.28% | +48.41% | +42.76% |
| Gross Profit Growth | +95.57% | +105.47% | +76.40% | +64.37% | +46.31% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.66% | +6.42% | +7.66% | +7.41% | +7.14% |
| Weighted Average Shares Diluted Growth | +7.66% | +6.42% | +7.66% | +7.41% | +7.14% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +99.43% | +72.60% | +41.34% | +37.17% | +22.38% |
| Inventory Growth | +20.49% | +41.28% | +49.75% | +52.81% | +31.20% |
| Asset Growth | -11.16% | +31.95% | +35.64% | +37.05% | +36.72% |
| Book Value per Share Growth | -25.15% | +34.62% | +36.90% | +42.66% | +47.14% |
| Debt Growth | +1.13% | +1.32% | -1.93% | -2.04% | -2.12% |
| R&D Expense Growth | +43.51% | +3.93% | +25.36% | +0.75% | +9.25% |
| SG&A Expenses Growth | +29.83% | +33.04% | +39.39% | +37.97% | +38.23% |